RPRX

Royalty Pharma (RPRX)

Royalty Pharma PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RPRX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/28	20 : 10	GlobeNewswire Inc.	Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/23	05 : 10	GlobeNewswire Inc.	Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/23	05 : 00	GlobeNewswire Inc.	Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/17	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/13	21 : 15	GlobeNewswire Inc.	Royalty Pharma to Present at Upcoming Investor Conferences	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	22 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	20 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	20 : 00	GlobeNewswire Inc.	Royalty Pharma Reports First Quarter 2024 Results	NASDAQ:RPRX	Royalty Pharma PLC
2024/05/09	19 : 45	GlobeNewswire Inc.	Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab	NASDAQ:RPRX	Royalty Pharma PLC
2024/04/19	21 : 15	GlobeNewswire Inc.	Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:RPRX	Royalty Pharma PLC
2024/04/17	21 : 15	GlobeNewswire Inc.	Royalty Pharma Declares Second Quarter 2024 Dividend	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/29	06 : 15	GlobeNewswire Inc.	Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/15	23 : 05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/15	21 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/15	21 : 30	GlobeNewswire Inc.	Royalty Pharma Reports Q4 and Full Year 2023 Results	NASDAQ:RPRX	Royalty Pharma PLC
2024/02/06	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/31	06 : 15	GlobeNewswire Inc.	Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/19	22 : 15	GlobeNewswire Inc.	Royalty Pharma Announces Dividend Increase	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/08	21 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/08	21 : 00	GlobeNewswire Inc.	Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/04	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RPRX	Royalty Pharma PLC
2024/01/04	06 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RPRX	Royalty Pharma PLC
2023/12/30	06 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RPRX	Royalty Pharma PLC
2023/12/28	06 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2023/12/28	03 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RPRX	Royalty Pharma PLC
2023/12/20	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RPRX	Royalty Pharma PLC
2023/12/16	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RPRX	Royalty Pharma PLC
2023/12/14	06 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RPRX	Royalty Pharma PLC
2023/11/28	06 : 15	GlobeNewswire Inc.	Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference	NASDAQ:RPRX	Royalty Pharma PLC